Sanofi Launches "LeGoo"

On Tuesday, Sanofi (NYSE: SNY  ) announced the commercial launch of a new surgical product for stanching the flow of blood -- and it's not a clamp, a loop, or any of the other medical devices ordinarily used for this purpose. Instead, it's goo.

More precisely, it's "LeGoo" -- an "atraumatic intraluminal occlusion" gel acquired by Sanofi when it bought Pluromed in March 2012. When injected into a blood vessel, LeGoo molds itself to the shape of the vessel to form a plug, temporarily stopping blood flow. Then, because it is a biopolymer, the gel dissolves to allow blood flow to recommence -- either on its own within about 15 minutes, or at the initiative of the surgeon, who can remove the plug by cooling the blood vessel directly through ice application or cold saline infusion.

LeGoo has been approved for use in the U.S. since October 2011, but this is its first commercial launch here. In Europe, the product has already been used in more than 3,000 surgical procedures.

Sanofi's announcement did little for its stock price Tuesday, however. Shares dropped 0.3% to end the day at $48.79.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2222803, ~/Articles/ArticleHandler.aspx, 11/27/2014 5:41:33 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement